Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -28.96x is 25% below its 5-year average of -23.24x, around the middle of its 5-year range (-39.86x–-8.71x).
7.85% above its 12-month average of -31.43x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -32.53x.
INTEREST COVERAGE RATIO
-28.96x
INTEREST COVERAGE RATIO AVG TTM
-31.43x
INTEREST COVERAGE RATIO AVG 3Y
-27.61x
INTEREST COVERAGE RATIO AVG 5Y
-23.24x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.85%
CURRENT VS 3Y AVG
-4.90%
CURRENT VS 5Y AVG
-24.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-354.27%
vs the sector median at left
PROCEPT BioRobotics Corporation
Market Cap
$995.51M
Interest Coverage Ratio
-28.96x
TTM Avg
-31.43x
3Y Avg
-27.61x
5Y Avg
-23.24x
Market Cap
$993.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$998.69M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01B
Interest Coverage Ratio
-192.41x
TTM Avg
28.86x
3Y Avg
28.86x
5Y Avg
28.86x
Market Cap
$979.22M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$978.24M
Interest Coverage Ratio
-8.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$978.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
Market Cap
$971.74M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
3.01x
5Y Avg
2.79x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $995.51M | -28.96x | -31.43x | -27.61x | -23.24x |
| Vor Biopharma Inc. (VOR)vs › | $993.04M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.01B | -192.41x | 28.86x | 28.86x | 28.86x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.22M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $978.24M | -8.69x | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | -497.79x | 15.03x | 15.03x | 8.31x |
| Pacira BioSciences, Inc. (PCRX)vs › | $971.74M | 2.28x | 2.28x | 3.01x | 2.79x |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | N/A | N/A | N/A | N/A |
Interest Coverage
-29.0x
Debt/Equity
0.23
Current Ratio
6.55
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -32.53x |
| 2026-03-31 | -39.86x |
| 2025-12-31 | -34.72x |
| 2025-09-30 | -25.24x |
| 2025-06-30 | -24.79x |
| 2025-03-31 | -31.29x |
| 2024-12-31 | -20.34x |
| 2024-09-30 | -19.67x |
| 2024-06-30 | -26.05x |
| 2024-03-31 | -26.46x |
| 2023-12-31 | -26.27x |
| 2023-09-30 | -25.13x |
| 2023-06-30 | -26.55x |
| 2023-03-31 | -32.03x |
| 2022-12-31 | -28.91x |
| 2022-09-30 | -15.19x |
| 2022-06-30 | -12.40x |
| 2022-03-31 | -11.05x |
| 2021-12-31 | -11.69x |
| 2021-09-30 | -8.71x |
| 2021-06-30 | -9.19x |
| 2021-03-31 | -7.75x |
| 2020-12-31 | -7.46x |
| 2020-09-30 | -7.91x |
